EDGAR Filing Documents for 0000947871-13-000319

Form 13F-NT - Quarterly report filed by institutional managers, Notice:

SEC Accession No. 0000947871-13-000319

Filing Date

2013-05-13

Accepted

2013-05-13 14:17:10

Documents

Period of Report

2013-03-31

Effectiveness Date

2013-05-13

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 13F NOTICE	ss174941_13fnt.txt	13F-NT	2639
	Complete submission text file	0000947871-13-000319.txt		3576

Mailing Address FREISCHUETZGASSE 3 ZURICH V8 8004

Business Address FREISCHUETZGASSE 3 ZURICH V8 8004 41-61-275-9200

Adamant Biomedical Investments AG (Filer) CIK: 0001542336 (see all company filings)